Trevi TherapeuticsvsUnitedHealth

TRVI and UNH stock compared: price, dividend, valuation and results, from SEC filings.

TRVI

Trevi Therapeutics, Inc.

$13.72

Value $2.0B

+1.55%
TRVI's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Trevi Therapeutics (TRVI) has a market value of $2.0B and UnitedHealth (UNH) $300B. Over the last year, with dividends, TRVI moved +21.3% and UNH +8.2%. Dividend yield: TRVI none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TRVI$2.0B

    UNH$300B

    UNH is 153 times TRVI

  • Revenue, 12 months

    TRVI–

    UNH$450B

  • Net income, 12 months

    TRVI-$61M

    UNH$15.9B

  • Operating margin

    TRVI–

    UNH5.3%

  • ROIC

    TRVI-21.3%

    UNH11.3%

    32.6 points apart

  • P/E

    TRVI–

    UNH18.9

  • Dividend yield

    TRVI0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    TRVI+1,232.0%

    UNH-19.5%

    1,251.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TRVI+1,232.5%

UNH-19.5%

01000200020222023202420252026
Returns by period
PeriodTRVIWith dividendsUNHWith dividends
1 year since November 18, 2025+21.3%Price +21.3%+8.2%Price +5.4%
3 years since November 17, 2023+887.1%+114.5% a yearPrice +887.1%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+1,232.0%+67.8% a yearPrice +1,232.0%-19.5%-4.2% a yearPrice -26.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TRVITrevi TherapeuticsUNHUnitedHealth

Valuation

TRVIUNH
Valuation
Price$13.72$330.48
Market value$2.0B$300B
Enterprise value (EV)$1.7B$346B
P/E–18.9
P/E, 5-year median–25.0
P/B6.52.9
EV/EBIT–14.5
Free cash flow yield–7.6%

Results and growth

TRVIUNH
Results and growth
Revenue, 12 months–$450B
Net income, 12 months-$61M$15.9B
Free cash flow, 12 months-$62M$22.8B
Earnings per share, 12 months-$0.39$17.52
Revenue growth, year on year–11.8%
Revenue growth a year, past–+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

TRVIUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin–5.3%
Net margin–3.5%
ROIC-21.3%11.3%
ROE-26.0%15.5%

Balance sheet

TRVIUNH
Balance sheet
Cash$299M$28.5B
Total debt$527.0K$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

TRVIUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TRVI or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Trevi Therapeutics or UnitedHealth?

By market value, UnitedHealth ($300B) is about 153.4 times Trevi Therapeutics ($2.0B), at today's prices.

How did TRVI and UNH stock do over the last 5 years?

Since November 18, 2021, TRVI's price moved +1,232.0% and UNH's -26.5%. With dividends: TRVI +1,232.0% (+67.8% a year), UNH -19.5% (-4.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, TRVI or UNH?

The dividend yield at today's price is none for Trevi Therapeutics and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which is the better investment, Trevi Therapeutics or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.